Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172888618> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2172888618 abstract "Background Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous injections of clotting factor (CF) concentrates. This study sought to estimate the health and economic burden of haemophilia in Belgium. This is the first study of its type to be conducted, and reflects the Belgian authorities’ growing interest for haemophilia as part of their priority planning for rare and chronic diseases. Methods A probabilistic model was developed in order to estimate the lifetime haemophilia burden for the 2011 birth-year Belgian cohort. The health burden was initially expressed in disability-adjusted life years (DALYs) lost, this being the number of lost healthy years due to both disability and premature mortality. An incidence perspective was used in line with World Health Organization recommendations. The economic burden calculated from direct and indirect haemophilia-related costs was expressed in euro. Data was drawn from the literature if none was available from federal institutions or health insurance. Disability weights for DALY calculation were derived using generic quality-of-life tools such as SF-36 (36-item Short-Form Health Survey; for adults) and KINDL (generic quality-of-life instrument for children) compared to population norms. Analyses were stratified according to haemophilia type and severity. Results In Belgium, haemophilia resulted in 145 healthy years lost due to morbidity, invalidity or early death (or DALYs) in total (95% credible interval [CrI]=90-222), which represents an average of 11 DALYs per incident case with haemophilia (PWH) (95% CrI=8-15) during his life, varying according to haemophilia severity (17 DALYs for severe haemophilia, 12 DALYs for moderate, and 4 DALYs for mild). Mean total lifetime costs reached 7.8 million euro per PWH, 94.3% being direct costs and 5.7% indirect costs. Clotting factors accounted for 82.5% of direct costs. Conclusions Haemophilia represents both an economic and health burden, especially regarding on an individual patient level and especially for severe PWH. Initiatives to counteract this burden should be clearly identified and given full support, as this burden is likely to further increase in the future, especially from an economic perspective. Our study may also contribute towards a better global evaluation of haemophilia in the future." @default.
- W2172888618 created "2016-06-24" @default.
- W2172888618 creator A5008435049 @default.
- W2172888618 creator A5018700375 @default.
- W2172888618 creator A5023571921 @default.
- W2172888618 creator A5038261480 @default.
- W2172888618 creator A5063724695 @default.
- W2172888618 creator A5063725680 @default.
- W2172888618 creator A5067477787 @default.
- W2172888618 date "2013-01-01" @default.
- W2172888618 modified "2023-10-16" @default.
- W2172888618 title "The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease" @default.
- W2172888618 hasPublicationYear "2013" @default.
- W2172888618 type Work @default.
- W2172888618 sameAs 2172888618 @default.
- W2172888618 citedByCount "0" @default.
- W2172888618 crossrefType "journal-article" @default.
- W2172888618 hasAuthorship W2172888618A5008435049 @default.
- W2172888618 hasAuthorship W2172888618A5018700375 @default.
- W2172888618 hasAuthorship W2172888618A5023571921 @default.
- W2172888618 hasAuthorship W2172888618A5038261480 @default.
- W2172888618 hasAuthorship W2172888618A5063724695 @default.
- W2172888618 hasAuthorship W2172888618A5063725680 @default.
- W2172888618 hasAuthorship W2172888618A5067477787 @default.
- W2172888618 hasConcept C112930515 @default.
- W2172888618 hasConcept C120665830 @default.
- W2172888618 hasConcept C121332964 @default.
- W2172888618 hasConcept C126322002 @default.
- W2172888618 hasConcept C126451531 @default.
- W2172888618 hasConcept C133925201 @default.
- W2172888618 hasConcept C138816342 @default.
- W2172888618 hasConcept C144024400 @default.
- W2172888618 hasConcept C149923435 @default.
- W2172888618 hasConcept C159110408 @default.
- W2172888618 hasConcept C187212893 @default.
- W2172888618 hasConcept C2777232031 @default.
- W2172888618 hasConcept C2778385053 @default.
- W2172888618 hasConcept C2779951463 @default.
- W2172888618 hasConcept C2780664029 @default.
- W2172888618 hasConcept C2908647359 @default.
- W2172888618 hasConcept C2992139802 @default.
- W2172888618 hasConcept C3019080777 @default.
- W2172888618 hasConcept C61511704 @default.
- W2172888618 hasConcept C64332521 @default.
- W2172888618 hasConcept C71924100 @default.
- W2172888618 hasConcept C72563966 @default.
- W2172888618 hasConcept C99454951 @default.
- W2172888618 hasConceptScore W2172888618C112930515 @default.
- W2172888618 hasConceptScore W2172888618C120665830 @default.
- W2172888618 hasConceptScore W2172888618C121332964 @default.
- W2172888618 hasConceptScore W2172888618C126322002 @default.
- W2172888618 hasConceptScore W2172888618C126451531 @default.
- W2172888618 hasConceptScore W2172888618C133925201 @default.
- W2172888618 hasConceptScore W2172888618C138816342 @default.
- W2172888618 hasConceptScore W2172888618C144024400 @default.
- W2172888618 hasConceptScore W2172888618C149923435 @default.
- W2172888618 hasConceptScore W2172888618C159110408 @default.
- W2172888618 hasConceptScore W2172888618C187212893 @default.
- W2172888618 hasConceptScore W2172888618C2777232031 @default.
- W2172888618 hasConceptScore W2172888618C2778385053 @default.
- W2172888618 hasConceptScore W2172888618C2779951463 @default.
- W2172888618 hasConceptScore W2172888618C2780664029 @default.
- W2172888618 hasConceptScore W2172888618C2908647359 @default.
- W2172888618 hasConceptScore W2172888618C2992139802 @default.
- W2172888618 hasConceptScore W2172888618C3019080777 @default.
- W2172888618 hasConceptScore W2172888618C61511704 @default.
- W2172888618 hasConceptScore W2172888618C64332521 @default.
- W2172888618 hasConceptScore W2172888618C71924100 @default.
- W2172888618 hasConceptScore W2172888618C72563966 @default.
- W2172888618 hasConceptScore W2172888618C99454951 @default.
- W2172888618 hasOpenAccess W2172888618 @default.
- W2172888618 hasRelatedWork W1503206236 @default.
- W2172888618 hasRelatedWork W1594018353 @default.
- W2172888618 hasRelatedWork W1983779237 @default.
- W2172888618 hasRelatedWork W2016427670 @default.
- W2172888618 hasRelatedWork W2090839778 @default.
- W2172888618 hasRelatedWork W2130257575 @default.
- W2172888618 hasRelatedWork W2131839676 @default.
- W2172888618 hasRelatedWork W2245160491 @default.
- W2172888618 hasRelatedWork W2250078410 @default.
- W2172888618 hasRelatedWork W2332337778 @default.
- W2172888618 hasRelatedWork W2391461139 @default.
- W2172888618 hasRelatedWork W2618661761 @default.
- W2172888618 hasRelatedWork W2901088499 @default.
- W2172888618 hasRelatedWork W2920880361 @default.
- W2172888618 hasRelatedWork W2971415324 @default.
- W2172888618 hasRelatedWork W3080656808 @default.
- W2172888618 hasRelatedWork W3087221780 @default.
- W2172888618 hasRelatedWork W3127643281 @default.
- W2172888618 hasRelatedWork W43609241 @default.
- W2172888618 hasRelatedWork W53058679 @default.
- W2172888618 isParatext "false" @default.
- W2172888618 isRetracted "false" @default.
- W2172888618 magId "2172888618" @default.
- W2172888618 workType "article" @default.